XML 112 R91.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value
6 Months Ended 12 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Fair Value [Abstract]    
Fair Value

11. Fair Value

        Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date. The three broad levels of fair value hierarchy are as follows:

  • Level 1—Quoted prices in active markets are available for identical assets or liabilities as of the reported date.

    Level 2—Quoted prices in markets that are not active or other pricing inputs that are either directly or indirectly observable as of the reported date.

    Level 3—Prices or valuation techniques that are both significant to the fair value measurement and unobservable as of the reported date. These financial instruments do not have two-way markets and are measured using management's best estimate of fair value, where the inputs into the determination of fair value require significant management judgment or estimation.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

        The following tables summarize the valuation of our financial instruments by pricing observability levels as of June 30, 2013 and December 31, 2012:

 
  June 30, 2013  
 
  Level 1   Level 2   Level 3   Total  
 
  (in thousands)
 

Money markets

  $ 275,458   $   $   $ 275,458  

U.S. Treasury Bills

        824,061         824,061  

U.K. Treasury Bills

        117         117  

Equity securities

                         

Growth

    116,486             116,486  

Value

    36,356             36,356  

Multi-asset and asset allocation

    50,195             50,195  

Other(1)

    56,399             56,399  

Fixed Income securities

                         

Taxable(2)

    146,730     2,968         149,698  

Tax-exempt(3)

    5,227     795         6,022  

Derivatives

    1,619     6,007         7,626  

Long exchange-traded options

    13,074             13,074  

Private equity

    5,229     19,221     61,426     85,876  
                   

Total assets measured at fair value

  $ 706,773   $ 853,169   $ 61,426   $ 1,621,368  
                   

Securities sold not yet purchased

                         

Short equities—corporate

  $ 37,769   $   $   $ 37,769  

Short exchange-traded options

    15,065             15,065  

Derivatives

    70     1,208         1,278  
                   

Total liabilities measured at fair value

  $ 52,904   $ 1,208   $   $ 54,112  
                   


 

 
  December 31, 2012  
 
  Level 1   Level 2   Level 3   Total  
 
  (in thousands)
 

Money markets

  $ 170,120   $   $   $ 170,120  

U.S. Treasury Bills

        1,537,150         1,537,150  

U.K. Treasury Bills

        125         125  

Equity securities

                         

Growth

    125,242             125,242  

Value

    36,126             36,126  

Multi-asset and asset allocation

    59,449             59,449  

Other(1)

    39,702             39,702  

Fixed Income securities

                         

Taxable(2)

    177,635     1,219         178,854  

Tax-exempt(3)

    5,661     797         6,458  

Derivatives

    64     2,561         2,625  

Long exchange-traded options

    15,087             15,087  

Private equity

    7,695         76,953     84,648  
                   

Total assets measured at fair value

  $ 636,781   $ 1,541,852   $ 76,953   $ 2,255,586  
                   

Securities sold not yet purchased

                         

Short equities—corporate

  $ 54,370   $   $   $ 54,370  

Short exchange-traded options

    9,197             9,197  

Other

    271             271  

Derivatives

    1,598     5,472         7,070  
                   

Total liabilities measured at fair value

  $ 65,436   $ 5,472   $   $ 70,908  
                   

(1)
Primarily long positions in corporate equities traded through our options desk.

(2)
Primarily corporate and government securities.

(3)
Primarily municipal bonds.

        Following is a description of the fair value methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy:

  • Money markets:  We invest excess cash in various money market funds that are valued based on quoted prices in active markets; these are included in Level 1 of the valuation hierarchy.

    Treasury Bills:  We hold United States Treasury Bills, which are primarily segregated in a special reserve bank custody account as required by Rule 15c3-3 of the Exchange Act. We also hold United Kingdom Treasury Bills. These securities are valued based on quoted yields in secondary markets and are included in Level 2 of the valuation hierarchy.

    Equity and fixed income securities:  Our equity and fixed income securities consist principally of company-sponsored mutual funds with net asset values and various separately managed portfolios consisting primarily of equity and fixed income securities with quoted prices in active markets, which are included in Level 1 of the valuation hierarchy. In addition, some securities are valued based on observable inputs from recognized pricing vendors, which are included in Level 2 of the valuation hierarchy.
  • Derivatives:  We hold exchange-traded futures with counterparties that are included in Level 1 of the valuation hierarchy. In addition, we also hold currency forward contracts, interest rate swaps, credit default swaps, option swaps and total return swaps with counterparties that are included in Level 2 of the valuation hierarchy.

    Options:  We hold long exchange-traded options that are included in Level 1 of the valuation hierarchy.

    Private equity:  Generally, the valuation of private equity investments owned by our consolidated venture capital fund requires significant management judgment due to the absence of quoted market prices, inherent lack of liquidity and the long-term nature of such investments. Private equity investments are valued initially at cost. The carrying values of private equity investments are adjusted either up or down from cost to reflect expected exit values as evidenced by financing and sale transactions with third parties, or when determination of a valuation adjustment is confirmed through ongoing review in accordance with our valuation policies and procedures. A variety of factors are reviewed and monitored to assess positive and negative changes in valuation including, but not limited to, current operating performance and future expectations of investee companies, industry valuations of comparable public companies, changes in market outlooks and the third party financing environment over time. In determining valuation adjustments resulting from the investment review process, particular emphasis is placed on current company performance and market conditions. For these reasons, which make the fair value of private equity investments unobservable, equity investments are included in Level 3 of the valuation hierarchy. However, if private equity investments owned by our consolidated venture capital fund become publicly traded, they are included in Level 1 of the valuation hierarchy. Also, if they contain trading restrictions, publicly traded equity investments are included in Level 2 of the valuation hierarchy. During the first quarter of 2012, one of our private securities went public and, due to a trading restriction period, $13.5 million was transferred from a Level 3 classification to a Level 2 classification. During the second quarter of 2013, one of our private securities went public and, due to a trading restriction period, $19.2 million was transferred from a Level 3 classification to a Level 2 classification.

    Securities sold not yet purchased:  Securities sold not yet purchased, primarily reflecting short positions in equities and exchange-traded options, are included in Level 1 of the valuation hierarchy.

        The following table summarizes the change in carrying value associated with Level 3 financial instruments carried at fair value:

 
  Three Months Ended
June 30,
  Six Months Ended
June 30,
 
 
  2013   2012   2013   2012  
 
  (in thousands)
 

Balance as of beginning of period

  $ 74,853   $ 58,235   $ 76,953   $ 64,466  

Transfers out

   
(19,220

)
 
   
(19,220

)
 
(13,548

)

Purchases

    87     1,988     97     3,833  

Sales

    (34 )   (1,823 )   (34 )   (1,823 )

Realized gains (losses), net

    (6,581 )   855     (6,581 )   855  

Unrealized gains (losses), net

    12,321     (1,347 )   10,211     4,125  
                   

Balance as of end of period

  $ 61,426   $ 57,908   $ 61,426   $ 57,908  
                   

        Transfers into and out of all levels of the fair value hierarchy are reflected at end-of-period fair values. Realized and unrealized gains and losses on Level 3 financial instruments are recorded in investment gains and losses in the condensed consolidated statements of income. A majority of the Level 3 investments are private equity investments owned by our consolidated venture capital fund, of which we own 10% and non-controlling interests own 90%.

        The following table provides quantitative information about Level 3 fair value measurements:

 
  Fair Value as
of June 30,
2013
  Valuation Technique   Unobservable Input   Range  
 
  (in thousands)
   
   
   
 

Private Equity:

                     

Technology, Media and Telecommunications

 
$

23,256
 

Market comparable

 

Revenue multiple

   
2.5–6.0
 

 

        companies   Discount rate     18 %

 

            Discount years     1.5  

Healthcare and Cleantech

 
$

1,849
 

Market comparable

 

Revenue multiple(1)

   
0.7–62.5
 

        companies   R&D multiple(1)     1.0–32.4  

            Discount for lack of marketability and risk factors     50–60 %

(1)
The median for the Healthcare and Cleantech revenue multiple is 8.4; the median R&D multiple is 5.2.

        The significant unobservable inputs used in the fair value measurement of the reporting entities' venture capital securities in the technology, media and telecommunications areas are enterprise value to revenue multiples and a discount rate to account for the time until the securities are likely monetized and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would result in a significantly lower (higher) fair value measurement.

        The significant unobservable inputs used in the fair value measurement of the reporting entities' venture capital securities in the healthcare and cleantech areas are enterprise value to revenue multiples, enterprise value to R&D investment multiples, and a discount for lack of marketability and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple and enterprise value to R&D investment multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount for lack of marketability and various risk factors in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption used for the level of enterprise value to revenue multiple is accompanied by a directionally similar change in the assumption used for the enterprise value to R&D multiple. In addition, a change in the assumption used for the discount for lack of marketability and various risk factors is not correlated to changes in the assumptions used for the enterprise value to revenue multiple or the enterprise value to R&D investment multiple.

        One of our private equity investments is a venture capital fund (fair value of $28.5 million and unfunded commitment of $12.2 million as of June 30, 2013) that invests in communications, consumer, digital media, healthcare and information technology markets. Another is an investment in a private equity fund focused exclusively on the energy sector (fair value of $7.7 million and unfunded commitment of $0.1 million as of June 30, 2013). In addition, one of the investments included in our consolidated private equity fund (fair value of $0.2 million and unfunded commitment of $0.2 million as of June 30, 2013) is a venture capital fund investing in clean energy, resource and energy efficiency and other sustainable industries. The fair value of each of these investments has been estimated using the capital account balances provided by the partnerships. The interests in these partnerships cannot be redeemed.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

        We did not have any material assets or liabilities that were measured at fair value for impairment on a nonrecurring basis during the three months ended June 30, 2013 or during the year ended December 31, 2012.

9. Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date. The three broad levels of fair value hierarchy are as follows:

Level 1—Quoted prices in active markets are available for identical assets or liabilities as of the reported date.

Level 2—Quoted prices in markets that are not active or other pricing inputs that are either directly or indirectly observable as of the reported date.

Level 3—Prices or valuation techniques that are both significant to the fair value measurement and unobservable as of the reported date. These financial instruments do not have two-way markets and are measured using management's best estimate of fair value, where the inputs into the determination of fair value require significant management judgment or estimation.
 
Assets Measured at Fair Value on a Recurring Basis

The following table summarizes the valuation of our financial instruments by pricing observability levels as of December 31, 2012 and 2011:

 
 
December 31, 2012
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
 
 
(in thousands)
 
 
 
 
 
Money markets
 
$
170,120
 
 
$
 
 
$
 
 
$
170,120
 
U.S. Treasury bills
 
 
 
 
 
1,537,150
 
 
 
 
 
 
1,537,150
 
U.K. Treasury bills
 
 
 
 
 
125
 
 
 
 
 
 
125
 
Equity securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Growth
 
 
125,242
 
 
 
 
 
 
 
 
 
125,242
 
Value
 
 
36,126
 
 
 
 
 
 
 
 
 
36,126
 
Multi-asset and asset allocation
 
 
59,449
 
 
 
 
 
 
 
 
 
59,449
 
Other(1)
 
 
39,702
 
 
 
 
 
 
 
 
 
39,702
 
Fixed Income securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taxable(2)
 
 
177,635
 
 
 
1,219
 
 
 
 
 
 
178,854
 
Tax-exempt(3)
 
 
5,661
 
 
 
797
 
 
 
 
 
 
6,458
 
Derivatives
 
 
64
 
 
 
2,561
 
 
 
 
 
 
2,625
 
Long exchange-traded options
 
 
15,087
 
 
 
 
 
 
 
 
 
15,087
 
Private equity
 
 
7,695
 
 
 
 
 
 
76,953
 
 
 
84,648
 
Total assets measured at fair value
 
$
636,781
 
 
$
1,541,852
 
 
$
76,953
 
 
$
2,255,586
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities sold not yet purchased
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short equities-corporate
 
$
54,370
 
 
$
 
 
$
 
 
$
54,370
 
Short exchange-traded options
 
 
9,197
 
 
 
 
 
 
 
 
 
9,197
 
Other
 
 
271
 
 
 
 
 
 
 
 
 
271
 
Derivatives
 
 
1,598
 
 
 
5,472
 
 
 
 
 
 
7,070
 
Total liabilities measured at fair value
 
$
65,436
 
 
$
5,472
 
 
$
 
 
$
70,908
 
 
 
 
December 31, 2011
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
 
 
(in thousands)
 
 
 
 
 
Money markets
 
$
340,548
 
 
$
 
 
$
 
 
$
340,548
 
U.S. Treasury bills
 
 
 
 
 
1,277,944
 
 
 
 
 
 
1,277,944
 
U.K. Treasury bills
 
 
 
 
 
119
 
 
 
 
 
 
119
 
Equity securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Growth
 
 
107,802
 
 
 
189
 
 
 
 
 
 
107,991
 
Value
 
 
60,096
 
 
 
9
 
 
 
 
 
 
60,105
 
Blend
 
 
118,208
 
 
 
 
 
 
 
 
 
118,208
 
Other(1)
 
 
45,583
 
 
 
 
 
 
 
 
 
45,583
 
Fixed Income securities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taxable(2)
 
 
110,062
 
 
 
14,488
 
 
 
 
 
 
124,550
 
Tax-exempt(3)
 
 
15,366
 
 
 
743
 
 
 
 
 
 
16,109
 
Other
 
 
17
 
 
 
 
 
 
 
 
 
17
 
Derivatives
 
 
127
 
 
 
3,494
 
 
 
 
 
 
3,621
 
Long exchange-traded options
 
 
14,322
 
 
 
 
 
 
 
 
 
14,322
 
Private equity
 
 
11,592
 
 
 
 
 
 
64,466
 
 
 
76,058
 
Total assets measured at fair value
 
$
823,723
 
 
$
1,296,986
 
 
$
64,466
 
 
$
2,185,175
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities sold not yet purchased
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short equities-corporate
 
$
34,469
 
 
$
 
 
$
 
 
$
34,469
 
Short exchange-traded options
 
 
3,567
 
 
 
 
 
 
 
 
 
3,567
 
Other
 
 
1,271
 
 
 
 
 
 
 
 
 
1,271
 
Derivatives
 
 
2,054
 
 
 
5,205
 
 
 
 
 
 
7,259
 
Total liabilities measured at fair value
 
$
41,361
 
 
$
5,205
 
 
$
 
 
$
46,566
 
 

(1)
Primarily long positions in corporate equities traded through our options desk.
(2)
Primarily corporate and government securities.
(3)
Primarily municipal bonds.
 
Following is a description of the fair value methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy:

Money markets: We invest excess cash in various money market funds that are valued based on quoted prices in active markets; these are included in Level 1 of the valuation hierarchy.

Treasury bills: We hold United States Treasury Bills, which are primarily segregated in a special reserve bank custody account as required by Rule 15c3-3 of the Exchange Act. We also hold United Kingdom Treasury Bills. These securities are valued based on quoted yields in secondary markets and are included in Level 2 of the valuation hierarchy.

Equity and fixed income securities: Our equity and fixed income securities consist principally of company-sponsored mutual funds with net asset values and various separately-managed portfolios consisting primarily of equity and fixed income securities with quoted prices in active markets, which are included in Level 1 of the valuation hierarchy. In addition, some securities are valued based on observable inputs from recognized pricing vendors, which are included in Level 2 of the valuation hierarchy.

Derivatives: We hold exchange-traded futures with counterparties that are included in Level 1 of the valuation hierarchy. In addition, we hold currency forward contracts, interest rate swaps, credit default swaps, option swaps and total return swaps with counterparties that are included in Level 2 of the valuation hierarchy.

Options: We hold long exchange-traded options that are included in Level 1 of the valuation hierarchy.

Private equity: Generally, the valuation of private equity investments owned by our consolidated venture capital fund requires significant management judgment due to the absence of quoted market prices, inherent lack of liquidity and the long-term nature of such investments. Private equity investments are valued initially at cost. The carrying values of private equity investments are adjusted either up or down from cost to reflect expected exit values as evidenced by financing and sale transactions with third parties, or when determination of a valuation adjustment is confirmed through ongoing review in accordance with our valuation policies and procedures. A variety of factors are reviewed and monitored to assess positive and negative changes in valuation including, but not limited to, current operating performance and future expectations of investee companies, industry valuations of comparable public companies, changes in market outlooks and the third party financing environment over time. In determining valuation adjustments resulting from the investment review process, particular emphasis is placed on current company performance and market conditions. For these reasons, which make the fair value of private equity investments unobservable, equity investments are included in Level 3 of the valuation hierarchy. However, if private equity investments owned by our consolidated venture capital fund become publicly-traded, they are included in Level 1 of the valuation hierarchy. Also, if they contain trading restrictions, publicly-traded equity investments are included in Level 2 of the valuation hierarchy. One of our private securities went public in the first quarter of 2011 and, due to a trading restriction period, $3.6 million was transferred from a Level 3 classification to a Level 2 classification. During the second quarter of 2011, the trading restriction period for one of our public securities lapsed, and, as a result, $20.6 million was transferred from a Level 2 classification to a Level 1 classification. During the third quarter of 2011, the trading restriction period for one of our public securities lapsed, and, as a result, $3.7 million was transferred from a Level 2 classification to a Level 1 classification. During the first quarter of 2012, one of our private securities went public and, due to a trading restriction period, $13.5 million was transferred from a Level 3 classification to a Level 2 classification. During the third quarter of 2012, the trading restriction period for one of our public securities lapsed and, as a result, $6.0 million was transferred from a Level 2 classification to a Level 1 classification.

Securities sold not yet purchased: Securities sold not yet purchased, primarily reflecting short positions in equities and exchange-traded options, are included in Level 1 of the valuation hierarchy.
 
The following table summarizes the change in carrying value associated with Level 3 financial instruments carried at fair value:

 
 
December 31,
2012
 
 
December 31,
2011
 
 
 
(in thousands)
 
 
 
 
 
 
 
 
Balance as of beginning of period
 
$
64,466
 
 
$
59,414
 
Transfers (out) in, net
 
 
(13,548
)
 
 
(3,588
)
Purchases
 
 
19,660
   
 
10,002
 
Sales
 
 
(1,823
)
 
 
(214
)
Realized gains (losses), net
 
 
(7,524
)
 
 
(3,106
)
Unrealized gains (losses), net
 
 
15,722
 
 
 
1,958
 
Balance as of end of period
 
$
76,953
 
 
$
64,466
 

Transfers into and out of all levels of the fair value hierarchy are reflected at end-of-period fair values. Realized and unrealized gains and losses on Level 3 financial instruments are recorded in investment gains and losses in the consolidated statements of income. A majority of the Level 3 investments are private equity investments owned by our consolidated venture capital fund, of which we own 10% and non-controlling interests own 90%.

The following table provides quantitative information about Level 3 fair value measurements:
 
 
 
Fair Value
as of
December
31, 2012
 
Valuation Technique
 
Unobservable
Input
 
Range
 
  
(in thousands)
        
Private Equity:
                    
Technology, Media and Telecommunications
 
$
23,256
 
Market comparable companies
 
Revenue multiple
   
2.5  – 6
 
             
Discount rate
   
18
%
             
Discount years
   
1 – 2
 
Healthcare and Cleantech
 
$
14,871
 
Market comparable companies
 
Revenue multiple(1)
   
0.6 – 62.5
 
             
R&D multiple(1)
   
1.0 – 30.6
 
             
Discount for lack of marketability and risk factors
   
40-60
%
 

(1)
The median for the Healthcare and Cleantech revenue multiple is 10.1; the majority of the R&D multiples fall between 4.0 and 11.4.

The significant unobservable inputs used in the fair value measurement of the reporting entities' venture capital securities in the technology, media and telecommunications areas are enterprise value to revenue multiples and a discount rate to account for the time until the securities are likely monetized and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would result in a significantly lower (higher) fair value measurement.

The significant unobservable inputs used in the fair value measurement of the reporting entities' venture capital securities in the healthcare and cleantech areas are enterprise value to revenue multiples, enterprise value to R&D investment multiples, and a discount for lack of marketability and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple and enterprise value to R&D investment multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount for lack of marketability and various risk factors in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption used for the level of enterprise value to revenue multiple is accompanied by a directionally similar change in the assumption used for the enterprise value to R&D multiple. In addition, a change in the assumption used for the discount for lack of marketability and various risk factors is not correlated to changes in the assumptions used for the enterprise value to revenue multiple or the enterprise value to R&D investment multiple.

We have one private equity investment, which is a venture capital fund (fair value of $29.9 million and unfunded commitment of $12.2 million as of December 31, 2012) investing in communications, consumer, digital media, healthcare and information technology markets. We also have a second private equity investment which is an investment in a private equity fund focused exclusively on the energy sector (fair value of $7.7 million and unfunded commitment of $0.2 million as of December 31, 2012). In addition, one of the investments included in our consolidated private equity fund (fair value of $1.2 million and unfunded commitment of $0.2 million as of December 31, 2012) is a venture capital fund investing in clean energy, resource and energy efficiency and other sustainable industries. The fair value of each of these investments has been estimated using the capital account balances provided by the partnerships. The interests in these partnerships cannot be redeemed.
 
Assets Measured at Fair Value on a Nonrecurring Basis
 
There were no impairments recognized for goodwill, intangible assets or other long-lived assets as of December 31, 2012.